BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 28119285)

  • 21. Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome.
    Busnadiego O; Gorbenko Del Blanco D; González-Santamaría J; Habashi JP; Calderon JF; Sandoval P; Bedja D; Guinea-Viniegra J; Lopez-Cabrera M; Rosell-Garcia T; Snabel JM; Hanemaaijer R; Forteza A; Dietz HC; Egea G; Rodriguez-Pascual F
    J Mol Cell Cardiol; 2015 Aug; 85():48-57. PubMed ID: 25988230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional changes in elastic fiber organization and transforming growth factor β signaling in aortas from a mouse model of marfan syndrome.
    Howell DW; Popovic N; Metz RP; Wilson E
    Cell Tissue Res; 2014 Dec; 358(3):807-19. PubMed ID: 25238995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgens Accentuate TGF-β Dependent Erk/Smad Activation During Thoracic Aortic Aneurysm Formation in Marfan Syndrome Male Mice.
    Tashima Y; He H; Cui JZ; Pedroza AJ; Nakamura K; Yokoyama N; Iosef C; Burdon G; Koyano T; Yamaguchi A; Fischbein MP
    J Am Heart Assoc; 2020 Oct; 9(20):e015773. PubMed ID: 33059492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent effects of canonical and non-canonical TGF-β signalling on mixed contractile-synthetic smooth muscle cell phenotype in human Marfan syndrome aortic root aneurysms.
    Pedroza AJ; Koyano T; Trojan J; Rubin A; Palmon I; Jaatinen K; Burdon G; Chang P; Tashima Y; Cui JZ; Berry G; Iosef C; Fischbein MP
    J Cell Mol Med; 2020 Feb; 24(3):2369-2383. PubMed ID: 31886938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
    Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
    Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome.
    De Cario R; Sticchi E; Lucarini L; Attanasio M; Nistri S; Marcucci R; Pepe G; Giusti B
    J Vasc Surg; 2018 Jul; 68(1):225-233.e5. PubMed ID: 28847661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome.
    Jespersen K; Li C; Batra R; Stephenson CA; Harding P; Sestak K; Foley RT; Greene H; Meisinger T; Cook JR; Baxter BT; Xiong W
    J Immunol Res; 2022; 2022():7538649. PubMed ID: 35211631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of HIPK2 Alleviates Thoracic Aortic Disease in Mice With Progressively Severe Marfan Syndrome.
    Caescu CI; Hansen J; Crockett B; Xiao W; Arnaud P; Spronck B; Weinberg A; Hashimoto T; Murtada SI; Borkar R; Gallo JM; Jondeau G; Boileau C; Humphrey JD; He JC; Iyengar R; Ramirez F
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2483-2493. PubMed ID: 34320838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan Patients.
    Yin 殷晓科 X; Wanga S; Fellows AL; Barallobre-Barreiro J; Lu R; Davaapil H; Franken R; Fava M; Baig F; Skroblin P; Xing Q; Koolbergen DR; Groenink M; Zwinderman AH; Balm R; de Vries CJM; Mulder BJM; Viner R; Jahangiri M; Reinhardt DP; Sinha S; de Waard V; Mayr M
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1859-1873. PubMed ID: 31315432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cystic disease in the Fbn1
    Hibender S; Wanga S; van der Made I; Vos M; Mulder BJ; Balm R; de Vries CJ; de Waard V
    Cardiovasc Pathol; 2019; 38():1-6. PubMed ID: 30359839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome.
    Zilberberg L; Phoon CK; Robertson I; Dabovic B; Ramirez F; Rifkin DB
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):14012-7. PubMed ID: 26494287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aortopathy in Marfan syndrome: an update.
    Romaniello F; Mazzaglia D; Pellegrino A; Grego S; Fiorito R; Ferlosio A; Chiariello L; Orlandi A
    Cardiovasc Pathol; 2014; 23(5):261-6. PubMed ID: 24925629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age and sex dependency of thoracic aortopathy in a mouse model of Marfan syndrome.
    Gharraee N; Sun Y; Swisher JA; Lessner SM
    Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H44-H56. PubMed ID: 34714692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Betaglycan (TGFBR3) up-regulation correlates with increased TGF-β signaling in Marfan patient fibroblasts in vitro.
    Groeneveld ME; Bogunovic N; Musters RJP; Tangelder GJ; Pals G; Wisselink W; Micha D; Yeung KK
    Cardiovasc Pathol; 2018; 32():44-49. PubMed ID: 29198452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous activation of BMP-2 signaling overcomes TGFβ-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells.
    Quarto N; Li S; Renda A; Longaker MT
    Stem Cells; 2012 Dec; 30(12):2709-19. PubMed ID: 23037987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell Type-Specific Contributions of the Angiotensin II Type 1a Receptor to Aorta Homeostasis and Aneurysmal Disease-Brief Report.
    Galatioto J; Caescu CI; Hansen J; Cook JR; Miramontes I; Iyengar R; Ramirez F
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):588-591. PubMed ID: 29371244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox Dysregulation of Vascular Smooth Muscle Sirtuin-1 in Thoracic Aortic Aneurysm in Marfan Syndrome.
    Budbazar E; Sulser Ponce De Leon S; Tsukahara Y; Liu H; Huangfu Y; Wang Y; Seabra PM; Yang X; Goodman JB; Wan X; Chitalia V; Han J; Seta F
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e339-e357. PubMed ID: 37288573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of TGF-β signaling in smooth muscle cell prevents elastase-induced abdominal aortic aneurysm.
    Gao F; Chambon P; Offermanns S; Tellides G; Kong W; Zhang X; Li W
    Biochem Biophys Res Commun; 2014 Nov; 454(1):137-43. PubMed ID: 25450370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome.
    Nettersheim FS; Lemties J; Braumann S; Geißen S; Bokredenghel S; Nies R; Hof A; Winkels H; Freeman BA; Klinke A; Rudolph V; Baldus S; Mehrkens D; Mollenhauer M; Adam M
    Cardiovasc Res; 2022 Jul; 118(9):2211-2225. PubMed ID: 34324651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome.
    Haskett D; Doyle JJ; Gard C; Chen H; Ball C; Estabrook MA; Encinas AC; Dietz HC; Utzinger U; Vande Geest JP; Azhar M
    Cell Tissue Res; 2012 Jan; 347(1):267-77. PubMed ID: 22105919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.